Gen9 announces appointment of Kevin Munnelly as president and chief executive
Gen9 Inc., a Cambridge company developing technologies for synthesizing genes, announced the appointment of Kevin Munnelly as president and chief executive. Company cofounder Joseph Jacobson had been serving as interim CEO. Munnelly joined Gen9 in September as chief operating officer, a post that will now be held by Martin Goldberg. Before joining Gen9, Munnelly was the general manager of a business unit of Life Technologies Corp.